JULIA MESSINEO: Open Payments
NPI 1053142489 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,671 in 69 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $345 · 2025 $1,671
Food & beverage: $1,671
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $507 |
| Lilly USA, LLC | 12 | $209 |
| Novo Nordisk Inc | 10 | $176 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $152 |
| PFIZER INC. | 6 | $116 |
| Exact Sciences Corporation | 4 | $88 |
| Collegium Pharmaceutical, Inc. | 3 | $66 |
| Eisai Inc. | 2 | $55 |
| Phathom Pharmaceuticals, Inc. | 2 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
Products named: AIRSUPRA, MOUNJARO, JARDIANCE, FARXIGA, BREZTRI, The Cologuard Plus Collection Kit, Jornay PM, Rybelsus.
Industry payments across NY — which companies pay providers there.
